Journals / Turkish Thoracic Journal / 2020 / Cilt: 21 - Sayı: 4

Immunoglobulin G4 Related Lung Disease

Pages
280–282
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The patient was treated successfully with glucocorticoids

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Immunoglobulin G4 related disease (IgG4-RD) is a relatively newly defined disease known for multiple organ involvement.
📊
Key Findings & Data:Histopathologically, the disease is characterized by lymphoplasmatic inflammation, fibrosis, and enhanced levels of IgG4-positive plasma cells in tissues.
💡
Conclusion & Impact:The patient was treated successfully with glucocorticoids
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Immunoglobulin G4 related disease (IgG4-RD) is a relatively newly defined disease known for multiple organ involvement. Histopathologically, the disease is characterized by lymphoplasmatic inflammation, fibrosis, and enhanced levels of IgG4-positive plasma cells in tissues. IgG4-RD has been reported in almost every organ system. With pulmonary involvement, lesions have been described in the lung parenchyma, airways, pleura, and the mediastinum. Glucocorticoids are the first choice of treatment, but additional immunosuppressive drugs may be administered in refractory patients. In this article, we report a patient with IgG4 syndrome who had lung parenchyma, mediastinum, aorta wall, and pancreatic involvement. Histopathological findings and high serum IgG4 level established the diagnosis of IgG4-related disease. The patient was treated successfully with glucocorticoids

🔖

Cite This Article

SEYHAN, E. C., ÖZGÜL, M. A., UĞUR, E., TURAN, D., ÜRER, N. (2022). Immunoglobulin G4 Related Lung Disease. Turkish Thoracic Journal, Cilt: 21 - Sayı: 4, 280–282. https://ajindex.com/articles/618101

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. 1 Khosroshahi A, Stone JH. A clinical overview of IgG4-related systemic disease. Curr Opin Rheumatol 2011;23:57-66. [CrossRef] 2. Pieringer H, Parzer I, Woehrer A, et al. IgG4-related disease: an orphan disease with many faces. Orphanet J Rare Dis 2014;9:110. doi: 10.1186/s13023-014-0110-z. [CrossRef] 3. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 2012;366:539-51. [CrossRef] 4. Montironi R, Scarpelli M, Cheng L, et al. Immunoglobulin G4-related disease in genitourinary organs: an emerging fibroinflammatory entity often misdiagnosed preoperatively as cancer. Eur Urol 2013;64:865-72. [CrossRef] 5. Della Torre E, Mattoo H, Mahajan VS, et al. Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease. Allergy 2014;69:269-72. [CrossRef] 6. Takuma K, Kamisawa T, Gopalakrishna R, et al. Strategy to differentiate autoimmune pancreatitis from pancreas cancer. World J Gastroenterol 2012;18:1015-20. [CrossRef] 7. Zen Y, Nakanuma YL. IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol 2010;34:1812-9. [CrossRef] 8. Stone JH, Khosroshahi A, Deshpande V, et al. IgG4-related systemic disease accounts for a significant proportion of thoracic lymphoplasmacytic aortitis cases. Arthritis Rare Res 2010;62:316-22. [CrossRef] 9. Inoue D, Zen Y, Abo H, Gabata T, et al. Immunoglobulin G4-related lung disease: CT findings with pathologic correlations. Radiology 2009;251:260-70. [CrossRef] 10. Campbell SN, Rubio E, Loschner AL. Clinical review of pulmonary manifestations of IgG4-related disease. Ann Am Thorac Soc 2014;11:1466-75. [CrossRef] 11. Carruthers MN, Khosroshahi A, Augustin T, et al. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis 2015;74: 14-8. [CrossRef] 12. Masaki Y, Kurose N, Yamamoto M, et al. Cutoff values of serum IgG4 and histopathological IgG4+ plasma cells fordiagnosis of patients with IgG4-related disease. Int J Rheumatol 2012; doi: 10.1155/2012/580814. Epub 2012 May 10. [CrossRef] 13. Zhang J, Chen H, Ma Y, et al. Characterizing IgG4-related disease with (1)(8)F-FDG PET/CT: a prospective cohort study. Eur J Nucl Med Mol Imaging 2014;41:1624-34. [CrossRef] 14. Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 2012;25:1181-92. [CrossRef] 15. Inoue M, Nose N, Nishikawa H, et al. Successful treatment of sclerosing mediastinitis with a high serum IgG4 level. Gen Thorac Cardiovas Surg 2007;55:431-3. [Cros